Pro Share Advisors LLC Mei Pharma, Inc. Transaction History

Pro Share Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.42 - $0.65 $10,069 - $15,583	-23,975 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$0.54 - $2.74 $154 - $786	287 Added 1.21%	23,975 $15,000
Q4 2021 Feb 08, 2022	BUY	$2.33 - $3.37 $22,824 - $33,012	9,796 Added 70.52%	23,688 $63,000
Q3 2021 Nov 12, 2021	SELL	$2.52 - $2.99 $35,867 - $42,556	-14,233 Reduced 50.61%	13,892 $38,000
Q2 2021 Aug 13, 2021	SELL	$2.6 - $3.65 $3,070 - $4,310	-1,181 Reduced 4.03%	28,125 $80,000
Q1 2021 May 14, 2021	BUY	$2.73 - $4.5 $13,685 - $22,558	5,013 Added 20.64%	29,306 $101,000
Q4 2020 Feb 09, 2021	BUY	$2.6 - $3.32 $30,243 - $38,618	11,632 Added 91.87%	24,293 $64,000
Q3 2020 Nov 13, 2020	SELL	$2.46 - $4.27 $3,394 - $5,892	-1,380 Reduced 9.83%	12,661 $40,000
Q2 2020 Aug 03, 2020	BUY	$1.45 - $4.3 $20,359 - $60,376	14,041 New	14,041 $58,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $370M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.